Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma
Hormone and Metabolic Research · 01.11.2024 · 56 (11) · 827-834
DOI: 10.1055/a-2314-0988 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.11.2024. Verfasst von Fakai Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Minimally Invasive Interventional Division, Shaanxi Provincial Cancer Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Warburg Effect, Oncologic, Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a primary liver cancer with a high mortality rate. The search for a new biomarker could help the prognosis of HCC patients. We identified the glycolytic gene set associated with HCC and the glycolytic lncRNA based on TCGA and MsigDB databases. According to these lncRNAs, K-means clustering, and regression analysis were performed on the patients. Two groups of HCC patients with different lncRNA expression levels were obtained based on K-means clustering results. The results of difference analysis and enrichment analysis showed that DEmRNA in the two HCC populations with significant survival differences was mainly enriched in transmembrane transporter complex, RNA polymerase II specificity, cAMP signaling pathway, and calcium signaling pathway. In addition, a prognostic model of HCC with 4 DElncRNAs was constructed based on regression analysis. ROC curve analysis showed that the model had good predictive performance. Drug predictionresults showed that the efficacy of JQ1, niraparib, and teniposide was higher in the low-risk group than in the high-risk group. In conclusion, this study preliminarily identified glycolytic-related prognostic features of lncRNAs in HCC and constructed a risk assessment model. The results of this study are expected to guide the prognosis assessment of clinical HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Minimally Invasive Interventional Division, Shaanxi Provincial Cancer Hospital, Xi'an, China.
Zitieren
APA
Qiu, F., Yu, G., Li, M., Li, Z., Zhang, Q., Mu, X., Cheng, Y., Zhai, P., & Liu, Q. (2024). Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma. Hormone and Metabolic Research, 56(11), 827-834. https://doi.org/10.1055/a-2314-0988
Vancouver
Qiu F, Yu G, Li M, Li Z, Zhang Q, Mu X, et al. Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma. Hormone and Metabolic Research. 2024;56(11):827-834. doi:10.1055/a-2314-0988
BibTeX
@article{Qiu2024,
author = {Qiu, Fakai and Yu, Guozheng and Li, Mei and Li, Zhubin and Zhang, Qinyang and Mu, Xudong and Cheng, Yuan and Zhai, Pengtao and Liu, Qunyi},
title = {Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {11},
pages = {827--834},
doi = {10.1055/a-2314-0988}
}
EUVIMED